N-glycan and Alzheimer's disease.
暂无分享,去创建一个
Naoyuki Taniguchi | N. Taniguchi | Yasuhiko Kizuka | S. Kitazume | Yasuhiko Kizuka | Shinobu Kitazume
[1] K. Ohtsubo,et al. Disease-associated glycans on cell surface proteins. , 2016, Molecular aspects of medicine.
[2] I. Grundke‐Iqbal,et al. Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease , 2002, FEBS letters.
[3] T. Iwatsubo,et al. Complex N‐glycosylated form of nicastrin is stabilized and selectively bound to presenilin fragments , 2002, FEBS letters.
[4] S. Younkin,et al. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. , 1993, Science.
[5] G. Hart,et al. The Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamine* , 1996, The Journal of Biological Chemistry.
[6] Y. Wada,et al. Brain Endothelial Cells Produce Amyloid β from Amyloid Precursor Protein 770 and Preferentially Secrete the O-Glycosylated Form* , 2010, The Journal of Biological Chemistry.
[7] William J. Ray,et al. A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain , 1999, Nature.
[8] M. Prince,et al. World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends , 2015 .
[9] H. Yonekawa,et al. In Vivo Cleavage of α2,6-Sialyltransferase by Alzheimer β-Secretase* , 2005, Journal of Biological Chemistry.
[10] P. Hiesinger,et al. Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells , 2012, The Journal of cell biology.
[11] P. Altevogt,et al. Functional role of N-glycosylation from ADAM10 in processing, localization and activity of the enzyme. , 2008, Biochimica et biophysica acta.
[12] Young-Choon Lee,et al. Screening a series of sialyltransferases for possible BACE1 substrates , 2006, Glycoconjugate Journal.
[13] B. Strooper,et al. BACE1 Physiological Functions May Limit Its Use as Therapeutic Target for Alzheimer's Disease , 2016, Trends in Neurosciences.
[14] P. Wong,et al. Bace1 modulates myelination in the central and peripheral nervous system , 2006, Nature Neuroscience.
[15] Rudi D'Hooge,et al. Phenotypic and Biochemical Analyses of BACE1- and BACE2-deficient Mice* , 2005, Journal of Biological Chemistry.
[16] K. Breen,et al. The role of the protein glycosylation state in the control of cellular transport of the amyloid β precursor protein , 1999, Neuroscience.
[17] M. Carrillo,et al. The biomarker-based diagnosis of Alzheimer's disease. 1—ethical and societal issues , 2017, Neurobiology of Aging.
[18] L. Tan,et al. TREM2 in Alzheimer’s disease , 2013, Molecular Neurobiology.
[19] S. Kitazume,et al. Excess APP O-glycosylation by GalNAc-T6 decreases A&bgr; production , 2017, Journal of biochemistry.
[20] Q. Wang,et al. Role of glycosylation in transport and enzymic activity of neutral endopeptidase-24.11. , 1994, The Biochemical journal.
[21] M. Mattson,et al. Increased Activity‐Regulating and Neuroprotective Efficacy of α‐Secretase‐Derived Secreted Amyloid Precursor Protein Conferred by a C‐Terminal Heparin‐Binding Domain , 1996, Journal of neurochemistry.
[22] H. Neumann,et al. Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease , 2010, ASN neuro.
[23] R. Ransohoff,et al. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models , 2015, The Journal of experimental medicine.
[24] D. Selkoe,et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.
[25] T. Saido,et al. Metabolic regulation of brain Abeta by neprilysin. , 2001, Science.
[26] Kelley W. Moremen,et al. Vertebrate protein glycosylation: diversity, synthesis and function , 2012, Nature Reviews Molecular Cell Biology.
[27] Thomas Kazen. Purification , 2004, Nature Biotechnology.
[28] J. Walter. The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases* , 2015, The Journal of Biological Chemistry.
[29] N. Kiyokawa,et al. The human CD10 lacking an N-glycan at Asn(628) is deficient in surface expression and neutral endopeptidase activity. , 2012, Biochimica et biophysica acta.
[30] G. Weskamp,et al. The Disintegrin/Metalloproteinase ADAM10 Is Essential for the Establishment of the Brain Cortex , 2010, The Journal of Neuroscience.
[31] B. de Strooper,et al. γ-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation , 2003, Journal of Cell Science.
[32] G. Evin,et al. β‐Site APP‐cleaving enzyme 1 trafficking and Alzheimer’s disease pathogenesis , 2012, Journal of neurochemistry.
[33] T. Miyatake,et al. N-linked oligosaccharide of beta-amyloid precursor protein (beta APP) of C6 glioma cells: putative regulatory role in beta APP processing. , 1995, Biochemical and biophysical research communications.
[34] A. Bernstein,et al. Presenilins are required for γ-secretase cleavage of β-APP and transmembrane cleavage of Notch-1 , 2000, Nature Cell Biology.
[35] P. Gleeson,et al. Dysregulation of intracellular trafficking and endosomal sorting in Alzheimer's disease: controversies and unanswered questions. , 2016, The Biochemical journal.
[36] R. Ransohoff,et al. Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer's disease. , 2016, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[37] B. de Strooper,et al. Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. , 2000, Nature Cell Biology.
[38] U. Schepers,et al. Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons , 2012, The EMBO journal.
[39] Louise Wickham,et al. Post-translational processing of β-secretase (BACE) and its ectodomain shedding: the pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid Aβ production , 2001 .
[40] T. Saido,et al. Reply to: 'Clearance of amyloid β-peptide from brain: transport or metabolism?' , 2000, Nature Medicine.
[41] J. Marth,et al. β-Galactoside α2,6-Sialyltransferase I Cleavage by BACE1 Enhances the Sialylation of Soluble Glycoproteins , 2007, Journal of Biological Chemistry.
[42] N. Taniguchi,et al. Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions. , 2016, The Biochemical journal.
[43] D. Westaway,et al. Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations , 2010, Cell.
[44] T. Saido,et al. Metabolic Regulation of Brain Aβ by Neprilysin , 2001, Science.
[45] B. Strooper,et al. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.
[46] Fei Liu,et al. Tau and neurodegenerative disease: the story so far , 2016, Nature Reviews Neurology.
[47] Chao Yu,et al. TNF-α regulates the proteolytic degradation of ST6Gal-1 and endothelial cell-cell junctions through upregulating expression of BACE1 , 2017, Scientific Reports.
[48] J. Rommens,et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.
[49] R. Firth. Function , 1955, Yearbook of Anthropology.
[50] Valerie A. Hale,et al. APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[51] R. Nixon,et al. Presenilin 1 Maintains Lysosomal Ca(2+) Homeostasis via TRPML1 by Regulating vATPase-Mediated Lysosome Acidification. , 2015, Cell reports.
[52] S. Kang,et al. Disease‐Associated Mutations of TREM2 Alter the Processing of N‐Linked Oligosaccharides in the Golgi Apparatus , 2015, Traffic.
[53] I. Grundke‐Iqbal,et al. Glycosylation of microtubule–associated protein tau: An abnormal posttranslational modification in Alzheimer's disease , 1996, Nature Medicine.
[54] K. Nave,et al. Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles , 2013, The EMBO journal.
[55] Harald Steiner,et al. PEN-2 Is an Integral Component of the γ-Secretase Complex Required for Coordinated Expression of Presenilin and Nicastrin* , 2002, The Journal of Biological Chemistry.
[56] A. Hofman,et al. Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.
[57] S. Howell,et al. Neutral endopeptidase can hydrolyze beta-amyloid(1-40) but shows no effect on beta-amyloid precursor protein metabolism. , 1995, Peptides.
[58] A. Pestronk,et al. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. , 2014, JAMA neurology.
[59] Panteleimon Giannakopoulos,et al. Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals , 2012, BMC Medicine.
[60] M. Colonna,et al. TREM2 variants: new keys to decipher Alzheimer disease pathogenesis , 2016, Nature Reviews Neuroscience.
[61] K. Ohtsubo,et al. Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins. , 2009, Carbohydrate research.
[62] D. Price,et al. Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm , 1997, Nature.
[63] M. Farzan,et al. The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E* , 2015, The Journal of Biological Chemistry.
[64] Y. Sakurai,et al. Increased bisecting and core-fucosylated N-glycans on mutant human amyloid precursor proteins , 2008, Glycoconjugate Journal.
[65] A. Bernstein,et al. Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1. , 2000, Nature cell biology.
[66] S. Kitazume,et al. Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[67] S. Kitazume,et al. Sialylation enhances the secretion of neurotoxic amyloid-beta peptides. , 2006, Journal of neurochemistry.
[68] P. S. St George-Hyslop,et al. Mature Glycosylation and Trafficking of Nicastrin Modulate Its Binding to Presenilins* 210 , 2002, The Journal of Biological Chemistry.
[69] E. Kremmer,et al. ADAM10 is the physiologically relevant, constitutive α‐secretase of the amyloid precursor protein in primary neurons , 2010, The EMBO journal.
[70] Meaghan Morris,et al. Tau post-translational modifications in wildtype and human amyloid precursor protein transgenic mice , 2015, Nature Neuroscience.
[71] Nobuhisa Iwata,et al. Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. , 2005, Nature medicine.
[72] E. Mandelkow,et al. Tau in physiology and pathology , 2015, Nature Reviews Neuroscience.
[73] T. Golde,et al. γ-Secretase inhibitors and modulators. , 2013, Biochimica et biophysica acta.
[74] C. Gaiteri,et al. Genetic variants in Alzheimer disease — molecular and brain network approaches , 2016, Nature Reviews Neurology.
[75] M. Staufenbiel,et al. An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease , 2015, EMBO molecular medicine.
[76] P. Tonali,et al. Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion‐body myopathy muscle , 2008, Journal of neurochemistry.
[77] Tsviya Olender,et al. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy , 2001, Nature Genetics.
[78] S. Kitazume,et al. Alzheimer's β-secretase, β-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[79] Naoyuki Taniguchi,et al. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics. , 2015, Advances in cancer research.
[80] H. Meziane,et al. Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[81] T. Saido,et al. Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition , 2000, Nature Medicine.
[82] Ajit Varki,et al. Biological roles of glycans , 2016, Glycobiology.
[83] P. Saftig,et al. Control of Peripheral Nerve Myelination by the ß-Secretase BACE1 , 2006, Science.
[84] S. Lichtenthaler. Alpha‐secretase in Alzheimer’s disease: molecular identity, regulation and therapeutic potential , 2011, Journal of neurochemistry.
[85] M. Mathes,et al. β‐Amyloid precursor protein is modified with O‐linked N‐acetylglucosamine , 1995, Journal of neuroscience research.
[86] S. Howell,et al. Neutral endopeptidase can hydrolyze β-amyloid(1–40) but shows no effect on β-amyloid precursor protein metabolism , 1995, Peptides.
[87] I. Grundke‐Iqbal,et al. Analysis of N‐glycans of pathological tau: possible occurrence of aberrant processing of tau in Alzheimer's disease , 2001, FEBS letters.
[88] Alison Abbott,et al. Dementia: A problem for our age , 2011, Nature.
[89] J. Marth,et al. Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction. , 1997, Glycobiology.
[90] D. Holtzman,et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques , 2016, The Journal of experimental medicine.
[91] S. Pinho,et al. Glycosylation in cancer: mechanisms and clinical implications , 2015, Nature Reviews Cancer.
[92] K. Mirnics,et al. A Role for Presenilins in Autophagy Revisited: Normal Acidification of Lysosomes in Cells Lacking PSEN1 and PSEN2 , 2012, The Journal of Neuroscience.
[93] Bengt Winblad,et al. The role of protein glycosylation in Alzheimer disease , 2014, The FEBS journal.
[94] K. Breen,et al. The over-expression of the wild type or mutant forms of the presenilin-1 protein alters glycoprotein processing in a human neuroblastoma cell line , 2003, Neuroscience Letters.
[95] D. Price,et al. Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice , 2008, Proceedings of the National Academy of Sciences.
[96] N. Seidah,et al. Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. , 2001, The Journal of biological chemistry.
[97] Louise Wickham,et al. Post-translational Processing of β-Secretase (β-Amyloid-converting Enzyme) and Its Ectodomain Shedding , 2001, The Journal of Biological Chemistry.
[98] L. Puglielli,et al. A reversible form of lysine acetylation in the ER and Golgi lumen controls the molecular stabilization of BACE1. , 2007, The Biochemical journal.
[99] G. Struhl,et al. Nicastrin is required for Presenilin-mediated transmembrane cleavage in Drosophila , 2001, Nature Cell Biology.
[100] S. Younkin,et al. Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)* , 2015, The Journal of Biological Chemistry.
[101] D. Holtzman,et al. TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model , 2015, Cell.
[102] N. Taniguchi,et al. Purification, cDNA cloning, and expression of UDP-N-acetylglucosamine: beta-D-mannoside beta-1,4N-acetylglucosaminyltransferase III from rat kidney. , 1992, The Journal of biological chemistry.
[103] C. Haass,et al. Trafficking and proteolytic processing of APP. , 2012, Cold Spring Harbor perspectives in medicine.
[104] A. Singleton,et al. TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.
[105] Ruedi Aebersold,et al. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing , 2000, Nature.
[106] P. Wong,et al. Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects , 2014, Journal of neurochemistry.
[107] E. Kremmer,et al. The Novel Membrane Protein TMEM59 Modulates Complex Glycosylation, Cell Surface Expression, and Secretion of the Amyloid Precursor Protein* , 2010, The Journal of Biological Chemistry.
[108] J. Trojanowski,et al. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.
[109] B. Strooper,et al. Total inactivation of γ–secretase activity in presenilin-deficient embryonic stem cells , 2000, Nature Cell Biology.
[110] E. Koo,et al. Activity-Induced Convergence of APP and BACE-1 in Acidic Microdomains via an Endocytosis-Dependent Pathway , 2013, Neuron.
[111] D. Selkoe,et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. , 1992, Nature.
[112] Christine Van Broeckhoven,et al. The genetic landscape of Alzheimer disease: clinical implications and perspectives , 2015, Genetics in Medicine.
[113] D. Selkoe,et al. Resolving controversies on the path to Alzheimer's therapeutics , 2011, Nature Medicine.
[114] D. Pollen,et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.
[115] Markus Aebi,et al. N-linked protein glycosylation in the ER. , 2013, Biochimica et biophysica acta.
[116] J. Marth,et al. Glycosylation in Cellular Mechanisms of Health and Disease , 2006, Cell.
[117] B. de Strooper,et al. The Neural Cell Adhesion Molecules L1 and CHL1 Are Cleaved by BACE1 Protease in Vivo* , 2012, The Journal of Biological Chemistry.
[118] R. Petersen,et al. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease , 2013, Molecular Neurodegeneration.
[119] S. Kitazume,et al. Sialylation enhances the secretion of neurotoxic amyloid‐β peptides , 2006 .
[120] M. Molinari,et al. Consequences of individual N-glycan deletions and of proteasomal inhibition on secretion of active BACE. , 2008, Molecular biology of the cell.
[121] T. Miyatake,et al. N-Linked Oligosaccharide of β-Amyloid Precursor Protein (βAPP) of C6 Glioma-Cells: Putative Regulatory Role in βAPP Processing , 1995 .
[122] D. Soragna,et al. An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene , 2003, Journal of neurology, neurosurgery, and psychiatry.
[123] Wei Xu,et al. aph-1 and pen-2 Are Required for Notch Pathway Signaling, γ-Secretase Cleavage of βAPP, and Presenilin Protein Accumulation , 2002 .
[124] Matthew S Macauley,et al. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. , 2012, Nature chemical biology.
[125] Yutaka Kirino,et al. Cleavage of Alzheimer’s Amyloid Precursor Protein (APP) by Secretases Occurs after O-Glycosylation of APP in the Protein Secretory Pathway , 1998, The Journal of Biological Chemistry.
[126] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.